-
61
Early Identification of the Non-Transplanted Functional High-Risk Multiple Myeloma: Insights from a Predictive Nomogram
Published 2025-01-01Subjects: “…multiple myeloma…”
Get full text
Article -
62
-
63
Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia
Published 2024-09-01Subjects: Get full text
Article -
64
Prognostic model and immune-infiltrating cell landscape based on differentially expressed autophagy-related genes in TP53-mutated multiple myeloma
Published 2021-07-01Subjects: “…multiple myeloma…”
Get full text
Article -
65
Long-term trends in the burden of multiple myeloma in China: a Joinpoint regression and age-period-cohort analysis based on GBD 2021
Published 2025-02-01Subjects: “…multiple myeloma…”
Get full text
Article -
66
5‐Hydroxymethylcytosine Profiles of cfDNA in Urine as Diagnostic, Differential Diagnosis and Prognostic Markers for Multiple Myeloma
Published 2024-12-01Subjects: Get full text
Article -
67
Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
68
The prognostic value of the platelet-to-lymphocyte ratio in multiple myeloma patients treated with a bortezomib-based regimen
Published 2025-01-01Subjects: Get full text
Article -
69
Elevated LIF and JAK-STAT activation drive severe COVID-19 in myeloma patients receiving the BCMA-CD3 bispecific antibody Elranatamab
Published 2025-01-01Subjects: “…Multiple myeloma…”
Get full text
Article -
70
Unveiling causal immune cell–gene associations in multiple myeloma: insights from systematic reviews and Mendelian randomization analyses
Published 2025-01-01Subjects: Get full text
Article -
71
Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations
Published 2025-01-01Subjects: Get full text
Article -
72
PNPO‐Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt/β‐Catenin Pathway
Published 2025-02-01Subjects: Get full text
Article -
73
Detection of early relapse in multiple myeloma patients
Published 2025-01-01Subjects: “…Multiple myeloma…”
Get full text
Article -
74
Characteristics and outcomes of secondary acute lymphoblastic leukemia (sALL) after multiple myeloma (MM): SEER data analysis in a single-center institution
Published 2025-01-01Subjects: “…Multiple myeloma…”
Get full text
Article -
75
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma
Published 2024-12-01Subjects: Get full text
Article -
76
Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
Published 2025-02-01Subjects: Get full text
Article -
77
Anti-GluK2 antibody-positive autoimmune encephalitis concurrent with multiple myeloma: a case report
Published 2025-01-01Subjects: Get full text
Article -
78
A Nomogram Based on Circulating Inflammatory Factors for Predicting Prognosis of Newly Diagnosed Multiple Myeloma Patients
Published 2025-02-01Subjects: “…multiple myeloma…”
Get full text
Article -
79
Unmasking Multiple Myeloma: The Importance of Suspecting Malignancy in Atypical Chronic Pain Mimicking Degenerative Conditions—A Case Report
Published 2025-01-01Subjects: Get full text
Article -
80
Engineered T cells secreting αB7-H3-αCD3 bispecific engagers for enhanced anti-tumor activity against B7-H3 positive multiple myeloma: a novel therapeutic approach
Published 2025-01-01Subjects: “…Multiple myeloma…”
Get full text
Article